Literature DB >> 14702882

Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision.

R Basson1, S Leiblum, L Brotto, L Derogatis, J Fourcroy, K Fugl-Meyer, A Graziottin, J R Heiman, E Laan, C Meston, L Schover, J van Lankveld, W Weijmar Schultz.   

Abstract

In light of various shortcomings of the traditional nosology of women's sexual disorders for both clinical practice and research, an international multi-disciplinary group has reviewed the evidence for traditional assumptions about women's sexual response. It is apparent that fullfilment of sexual desire is an uncommon reason/incentive for sexual activity for many women and, in fact, sexual desire is frequently experienced only after sexual stimuli have elicited subjective sexual arousal. The latter is often poorly correlated with genital vasocongestion. Complaints of lack of subjective arousal despite apparently normal genital vasocongestion are common. Based on the review of existing evidence-based research, many modifications to the definitions of women's sexual dysfunctions are recommended. There is a new definition of sexual interest/desire disorder, sexual arousal disorders are separated into genital and subjective subtypes and the recently recognized condition of persistent sexual arousal is included. The definition of dyspareunia reflects the possibility of the pain precluding intercourse. The anticipation and fear of pain characteristic of vaginismus is noted while the assumed muscular spasm is omitted given the lack of evidence. Finally, a recommendation is made that all diagnoses be accompanied by descriptors relating to associated contextual factors and to the degree of distress.

Entities:  

Mesh:

Year:  2003        PMID: 14702882     DOI: 10.3109/01674820309074686

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  29 in total

1.  [The prevalence of sexual problems in female medical students].

Authors:  R Dieckmann; M Oelke; S Uckert; J-U Stolzenburg; H Sperling; C G Stief; U Jonas; M C Truss; U Hartmann
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

2.  The impact of anxiety on sexual arousal in women.

Authors:  Andrea Bradford; Cindy M Meston
Journal:  Behav Res Ther       Date:  2005-09-30

3.  Consensus statement on management of intersex disorders.

Authors:  I A Hughes; C Houk; S F Ahmed; P A Lee
Journal:  Arch Dis Child       Date:  2006-04-19       Impact factor: 3.791

4.  Cues resulting in desire for sexual activity in women.

Authors:  Katie McCall; Cindy Meston
Journal:  J Sex Med       Date:  2006-09       Impact factor: 3.802

Review 5.  [Female sexual dysfunction].

Authors:  J B Korda
Journal:  Urologe A       Date:  2008-01       Impact factor: 0.639

6.  Women's Experiences With Feelings and Attractions for Someone Outside their Primary Relationship.

Authors:  Margo Mullinax; Katie Jo Barnhart; Kristen Mark; Debby Herbenick
Journal:  J Sex Marital Ther       Date:  2015-07-16

7.  An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction.

Authors:  Rebecca G Rogers; Rachel N Pauls; Ranee Thakar; Melanie Morin; Annette Kuhn; Eckhard Petri; Brigitte Fatton; Kristene Whitmore; Sheryl A Kingsberg; Joseph Lee
Journal:  Int Urogynecol J       Date:  2018-03-26       Impact factor: 2.894

Review 8.  Interventions for vaginismus.

Authors:  Tamara Melnik; Keith Hawton; Hugh McGuire
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 9.  Evaluation and treatment of female sexual disorders.

Authors:  Sheryl Kingsberg; Stanley E Althof
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05

10.  The sensitivity of event logs, self-administered questionnaires and photoplethysmography to detect treatment-induced changes in female sexual arousal disorder (FSAD) diagnosis.

Authors:  Alessandra Rellini; Cindy Meston
Journal:  J Sex Med       Date:  2006-03       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.